|
|
| Maladies Cardiovasculaires > Etude de marché sectorielle |
| Cardiovascular Disease Diagnostics |
|
|
|
|
€ 3 091,00 |
Editeur
: |
Global Industry Analyst |
Langue
: |
Anglais |
Date de publication : |
Octobre 2005 |
Taille du document : |
380 |
Autres informations : |
Description , Table des matières |
| |
|
|
|
|
| |
Documents Publics |
1,200,000
documents |
Téléchargement illimités |
|
|
|
Etudes Privées |
50,000 rapports et études |
Paiement à la piéce |
|
|
|
|
| |
|
1.Télécharger nos rapports publics
Accés complet à plus de 1,2 Million de documents publics : études de marché, statistiques sectorielles, fiches pays, monographie d'entreprises, veille concurentielle, rapports annuels...
|
| Nos documents publics sur le même théme (1) |
|
|
|
| 36 pages | Décembre 2004 | Anglais
|
|
|
| Main
focus: |
cardiovascular disease,heart failure,...,cancer,...
|
| Research
focus: |
market outlook,market segmentation,demand analysis, |
| Geographic
focus: |
new zealand,usa,australia,united kingdom,... |
| |
|
|
|
|
| Autres recherches sur le même thème |
|
|
|
| |
| |
|
| |
|
2.
Rechercher d'autres rapports et études à commander
Rechercher et commander ici parmi 50.000 études de marché publiées par les principaux instituts d'études internationaux
|
| Rapports privés en relation |
|
Chinese Markets for Cardiovascular Drugs
235 pages | Octobre 2002 |
China's demand for cardiovascular drugs has grown at a fast pace in the past decade.
In the next five years, both production and demand will continue to grow.
This new study examines China's eco |
2 835,00 €
|
| |
| |
Nutraceuticals - Targeting Consumers Aged 35+
154 pages | Septembre 2000 |
Not only does the 35+ consumer group account for a significant and growing percentage of the total population; it is also at the greatest risk of major illnesses.
Despite advances in medicine |
955,00 €
|
| |
| |
The World Hypertension Market 2005-2010
185 pages | Novembre 2005 |
The world hypertension market generated over $25 billion in 2004, with steady growth from the previous year.
In this report, visiongain forecasts that revenues in the world hypertension market will |
2 663,00 €
|
| |
| |
Hypertension and Diabetic Kidney Disease - Prevalence, current treatment and future options
71 pages | Octobre 2005 |
IntroductionThe increase in diabetic kidney disease is a worldwide problem.
Current treatment centers on antihypertensives inhibitors for the renin-angiotensin system and merely retards the decline |
3 230,00 €
|
| |
| |
Commercial Insight: Antidiabetics - Billion Dollar Drugs, Pipeline Dreams?
107 pages | Juillet 2005 |
IntroductionThe diabetes epidemic has contributed to the expansion of the antidiabetics market in the past few years, and with prevalence increasing, this trend is set to continue.
However, the hig |
12 160,00 €
|
| |
| |
US Cholesterol-Reducing Statins 2004
12 pages | Décembre 2004 |
Snapdata's US Cholesterol-Reducing Statins 2004 report provides 2003 year-end market data, with 2004 estimates and five-year forecasts.
The report gives an instant overview of the US cholesterol-re |
240,00 €
|
| |
| |
Cholesterol and Other Cardiovascular Testing
244 pages | Août 2005 |
This report analyzes the worldwide markets for Cholesterol & Other Cardiovascular Testing in Millions of Units.
The specific product segments analyzed are Lipid Panel Test/Complete Lipid Profile, T |
2 308,00 €
|
| |
| |
The Cardiovascular Outlook 1998-2010
186 pages | Août 1999 |
In 1998, the global cardiovascular market expanded by 7.2%, growing in value from $60bn in 1997 to almost $65bn in 1998.
Market expansion is being driven by expanding prevalent populations in t |
795,00 €
|
| |
| |
UK Market For Fitness Equipment
90 pages | Juillet 2002 |
This report will enable you to:Analyse the size of the UK market for fitness equipment, in value terms, 1997-2006Quantify the size of the UK market for commercial cardiovascular fitness equipment, 1 |
698,00 €
|
| |
| |
Merck KGaA: PharmaVitae Profile 2005
121 pages | Décembre 2005 |
IntroductionThis analysis examines the current position and future outlook for Merck KGaA in the ethical pharmaceutical sector.
The profile encompasses global company strategy, portfolio and pipeli |
4 845,00 €
|
| |
| |
|
| |
| Autres secteurs en relation |
|
|
|
| |
|
| |
| |
| Présentation de l'étude de marché - Description & Table des matières |
|
| Cardiovascular Disease Diagnostics |
|
|
This report analyzes the worldwide markets for Cardiovascular Disease Diagnostics in Millions of US$. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle East, and Latin America. Annual forecasts are provided for each region for the period of 2000 through 2010. The report profiles 67 companies including many key and niche players worldwide such as Abbott Diagnostics ,Biosite, Inc., Cambridge Heart, Inc., Cholestech Corp., Dade Behring, Inc., EP Medsystems, GE HealthCare, Liposcience, Inc., Philips Medical Systems, Roche Diagnostics ,Siemens Medical Solutions, and Spectral Diagnostics, Inc.
|
|
Cardiovascular Disease Diagnostics
|
|
|
PPLSEN
|
|
|
|
|
